nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—CYP1A1—Dacarbazine—pancreatic cancer	0.0628	0.0958	CbGbCtD
Rabeprazole—ABCG2—Tamoxifen—pancreatic cancer	0.0542	0.0826	CbGbCtD
Rabeprazole—CYP1A1—Tamoxifen—pancreatic cancer	0.05	0.0762	CbGbCtD
Rabeprazole—ABCG2—Erlotinib—pancreatic cancer	0.046	0.0702	CbGbCtD
Rabeprazole—CYP1A1—Erlotinib—pancreatic cancer	0.0425	0.0648	CbGbCtD
Rabeprazole—ABCG2—Irinotecan—pancreatic cancer	0.0416	0.0634	CbGbCtD
Rabeprazole—ABCG2—Fluorouracil—pancreatic cancer	0.0399	0.0608	CbGbCtD
Rabeprazole—ATP4A—gastric juice—pancreatic cancer	0.0376	0.77	CbGeAlD
Rabeprazole—ABCG2—Docetaxel—pancreatic cancer	0.0305	0.0465	CbGbCtD
Rabeprazole—ABCG2—Sunitinib—pancreatic cancer	0.0303	0.0462	CbGbCtD
Rabeprazole—CYP1A2—Dacarbazine—pancreatic cancer	0.0281	0.0428	CbGbCtD
Rabeprazole—CYP2C19—Tamoxifen—pancreatic cancer	0.0242	0.0369	CbGbCtD
Rabeprazole—ABCG2—Doxorubicin—pancreatic cancer	0.0227	0.0346	CbGbCtD
Rabeprazole—CYP1A2—Tamoxifen—pancreatic cancer	0.0223	0.034	CbGbCtD
Rabeprazole—CYP2C9—Tamoxifen—pancreatic cancer	0.0201	0.0307	CbGbCtD
Rabeprazole—CYP1A2—Erlotinib—pancreatic cancer	0.019	0.0289	CbGbCtD
Rabeprazole—CYP2D6—Tamoxifen—pancreatic cancer	0.0184	0.0281	CbGbCtD
Rabeprazole—CYP1A2—Fluorouracil—pancreatic cancer	0.0165	0.0251	CbGbCtD
Rabeprazole—CYP2D6—Erlotinib—pancreatic cancer	0.0156	0.0239	CbGbCtD
Rabeprazole—CYP2C9—Fluorouracil—pancreatic cancer	0.0148	0.0226	CbGbCtD
Rabeprazole—ATP4A—Secretion of Hydrochloric Acid in Parietal Cells—GAST—pancreatic cancer	0.0132	0.207	CbGpPWpGaD
Rabeprazole—CYP3A4—Tamoxifen—pancreatic cancer	0.0117	0.0178	CbGbCtD
Rabeprazole—CYP3A4—Erlotinib—pancreatic cancer	0.00995	0.0152	CbGbCtD
Rabeprazole—CYP3A4—Irinotecan—pancreatic cancer	0.00898	0.0137	CbGbCtD
Rabeprazole—CYP2D6—Doxorubicin—pancreatic cancer	0.00772	0.0118	CbGbCtD
Rabeprazole—ATP4B—Ion transport by P-type ATPases—FXYD3—pancreatic cancer	0.00709	0.111	CbGpPWpGaD
Rabeprazole—CYP3A4—Docetaxel—pancreatic cancer	0.00658	0.01	CbGbCtD
Rabeprazole—CYP3A4—Sunitinib—pancreatic cancer	0.00655	0.00999	CbGbCtD
Rabeprazole—ATP4A—Ion transport by P-type ATPases—FXYD3—pancreatic cancer	0.00632	0.0988	CbGpPWpGaD
Rabeprazole—ATP4B—digestive system—pancreatic cancer	0.00527	0.108	CbGeAlD
Rabeprazole—CYP3A4—Doxorubicin—pancreatic cancer	0.00491	0.00748	CbGbCtD
Rabeprazole—ATP4B—Ion channel transport—FXYD3—pancreatic cancer	0.00246	0.0383	CbGpPWpGaD
Rabeprazole—ATP4A—digestive system—pancreatic cancer	0.00229	0.047	CbGeAlD
Rabeprazole—ATP4A—Ion channel transport—FXYD3—pancreatic cancer	0.00219	0.0342	CbGpPWpGaD
Rabeprazole—ABCG2—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00149	0.0232	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000855	0.0133	CbGpPWpGaD
Rabeprazole—CYP2C19—digestive system—pancreatic cancer	0.000801	0.0164	CbGeAlD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000762	0.0119	CbGpPWpGaD
Rabeprazole—ABCG2—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000746	0.0117	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000697	0.0109	CbGpPWpGaD
Rabeprazole—CYP1A2—digestive system—pancreatic cancer	0.000654	0.0134	CbGeAlD
Rabeprazole—CYP1A1—digestive system—pancreatic cancer	0.000645	0.0132	CbGeAlD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000621	0.0097	CbGpPWpGaD
Rabeprazole—CYP2C9—digestive system—pancreatic cancer	0.000621	0.0127	CbGeAlD
Rabeprazole—ABCG2—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000592	0.00924	CbGpPWpGaD
Rabeprazole—CYP3A4—digestive system—pancreatic cancer	0.000473	0.0097	CbGeAlD
Rabeprazole—CYP2D6—digestive system—pancreatic cancer	0.000466	0.00954	CbGeAlD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	0.000456	0.00712	CbGpPWpGaD
Rabeprazole—CYP1A1—Oxidative Stress—NFE2L2—pancreatic cancer	0.00044	0.00686	CbGpPWpGaD
Rabeprazole—ABCG2—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000337	0.00527	CbGpPWpGaD
Rabeprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	0.000334	0.00521	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—AHR—pancreatic cancer	0.00032	0.005	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	0.00032	0.005	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	0.000312	0.00488	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—NFE2L2—pancreatic cancer	0.000312	0.00488	CbGpPWpGaD
Rabeprazole—ATP4B—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000263	0.00411	CbGpPWpGaD
Rabeprazole—ABCG2—HIF-2-alpha transcription factor network—KDR—pancreatic cancer	0.000262	0.0041	CbGpPWpGaD
Rabeprazole—CYP1A1—Oxidative Stress—SOD2—pancreatic cancer	0.000245	0.00382	CbGpPWpGaD
Rabeprazole—ATP4A—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000235	0.00366	CbGpPWpGaD
Rabeprazole—CYP1A1—Estrogen Receptor Pathway—STAT3—pancreatic cancer	0.000209	0.00327	CbGpPWpGaD
Rabeprazole—CYP1A1—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000206	0.00322	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—AHR—pancreatic cancer	0.000204	0.00319	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	0.000204	0.00319	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—pancreatic cancer	0.000199	0.00311	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	0.000199	0.00311	CbGpPWpGaD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	0.000197	0.00308	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000178	0.00278	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	0.000174	0.00272	CbGpPWpGaD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	0.000169	0.00264	CbGpPWpGaD
Rabeprazole—CYP2C19—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000169	0.00263	CbGpPWpGaD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	0.000161	0.00252	CbGpPWpGaD
Rabeprazole—CYP2D6—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000155	0.00242	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000145	0.00226	CbGpPWpGaD
Rabeprazole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—pancreatic cancer	0.000145	0.00226	CbGpPWpGaD
Rabeprazole—CYP1A2—Estrogen Receptor Pathway—STAT3—pancreatic cancer	0.000133	0.00208	CbGpPWpGaD
Rabeprazole—CYP1A2—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000131	0.00205	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	0.000119	0.00185	CbGpPWpGaD
Rabeprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000118	0.00184	CbGpPWpGaD
Rabeprazole—ABCG2—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000112	0.00175	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	0.000111	0.00173	CbGpPWpGaD
Rabeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000101	0.00157	CbGpPWpGaD
Rabeprazole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	9.93e-05	0.00155	CbGpPWpGaD
Rabeprazole—Hyperglycaemia—Epirubicin—pancreatic cancer	9.76e-05	0.000422	CcSEcCtD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	9.75e-05	0.00152	CbGpPWpGaD
Rabeprazole—Cough—Docetaxel—pancreatic cancer	9.75e-05	0.000422	CcSEcCtD
Rabeprazole—Angina pectoris—Doxorubicin—pancreatic cancer	9.75e-05	0.000422	CcSEcCtD
Rabeprazole—Hypersensitivity—Irinotecan—pancreatic cancer	9.72e-05	0.00042	CcSEcCtD
Rabeprazole—Pneumonia—Epirubicin—pancreatic cancer	9.7e-05	0.00042	CcSEcCtD
Rabeprazole—Convulsion—Docetaxel—pancreatic cancer	9.68e-05	0.000419	CcSEcCtD
Rabeprazole—Hypertension—Docetaxel—pancreatic cancer	9.65e-05	0.000417	CcSEcCtD
Rabeprazole—Bronchitis—Doxorubicin—pancreatic cancer	9.63e-05	0.000416	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	9.57e-05	0.000414	CcSEcCtD
Rabeprazole—Myalgia—Docetaxel—pancreatic cancer	9.52e-05	0.000411	CcSEcCtD
Rabeprazole—Arthralgia—Docetaxel—pancreatic cancer	9.52e-05	0.000411	CcSEcCtD
Rabeprazole—Chest pain—Docetaxel—pancreatic cancer	9.52e-05	0.000411	CcSEcCtD
Rabeprazole—Nausea—Sunitinib—pancreatic cancer	9.52e-05	0.000411	CcSEcCtD
Rabeprazole—Pancytopenia—Doxorubicin—pancreatic cancer	9.51e-05	0.000411	CcSEcCtD
Rabeprazole—Asthenia—Irinotecan—pancreatic cancer	9.47e-05	0.000409	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Epirubicin—pancreatic cancer	9.46e-05	0.000409	CcSEcCtD
Rabeprazole—Jaundice—Epirubicin—pancreatic cancer	9.4e-05	0.000407	CcSEcCtD
Rabeprazole—Stomatitis—Epirubicin—pancreatic cancer	9.4e-05	0.000407	CcSEcCtD
Rabeprazole—Urinary tract infection—Epirubicin—pancreatic cancer	9.38e-05	0.000405	CcSEcCtD
Rabeprazole—Conjunctivitis—Epirubicin—pancreatic cancer	9.38e-05	0.000405	CcSEcCtD
Rabeprazole—Dysuria—Doxorubicin—pancreatic cancer	9.36e-05	0.000405	CcSEcCtD
Rabeprazole—Neutropenia—Doxorubicin—pancreatic cancer	9.36e-05	0.000405	CcSEcCtD
Rabeprazole—Hypersensitivity—Fluorouracil—pancreatic cancer	9.31e-05	0.000403	CcSEcCtD
Rabeprazole—Dry mouth—Docetaxel—pancreatic cancer	9.31e-05	0.000402	CcSEcCtD
Rabeprazole—Sweating—Epirubicin—pancreatic cancer	9.25e-05	0.0004	CcSEcCtD
Rabeprazole—Pollakiuria—Doxorubicin—pancreatic cancer	9.25e-05	0.0004	CcSEcCtD
Rabeprazole—Asthenia—Gemcitabine—pancreatic cancer	9.22e-05	0.000399	CcSEcCtD
Rabeprazole—Haematuria—Epirubicin—pancreatic cancer	9.2e-05	0.000398	CcSEcCtD
Rabeprazole—Confusional state—Docetaxel—pancreatic cancer	9.2e-05	0.000398	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Doxorubicin—pancreatic cancer	9.14e-05	0.000395	CcSEcCtD
Rabeprazole—CYP1A1—Arachidonic acid metabolism—PTGS2—pancreatic cancer	9.13e-05	0.00143	CbGpPWpGaD
Rabeprazole—Anaphylactic shock—Docetaxel—pancreatic cancer	9.12e-05	0.000394	CcSEcCtD
Rabeprazole—Oedema—Docetaxel—pancreatic cancer	9.12e-05	0.000394	CcSEcCtD
Rabeprazole—Weight increased—Doxorubicin—pancreatic cancer	9.11e-05	0.000394	CcSEcCtD
Rabeprazole—Epistaxis—Epirubicin—pancreatic cancer	9.1e-05	0.000393	CcSEcCtD
Rabeprazole—Pruritus—Gemcitabine—pancreatic cancer	9.1e-05	0.000393	CcSEcCtD
Rabeprazole—Weight decreased—Doxorubicin—pancreatic cancer	9.06e-05	0.000392	CcSEcCtD
Rabeprazole—Sinusitis—Epirubicin—pancreatic cancer	9.05e-05	0.000391	CcSEcCtD
Rabeprazole—Hyperglycaemia—Doxorubicin—pancreatic cancer	9.03e-05	0.000391	CcSEcCtD
Rabeprazole—Diarrhoea—Irinotecan—pancreatic cancer	9.03e-05	0.00039	CcSEcCtD
Rabeprazole—Agranulocytosis—Epirubicin—pancreatic cancer	9e-05	0.000389	CcSEcCtD
Rabeprazole—Pneumonia—Doxorubicin—pancreatic cancer	8.98e-05	0.000388	CcSEcCtD
Rabeprazole—Shock—Docetaxel—pancreatic cancer	8.98e-05	0.000388	CcSEcCtD
Rabeprazole—Pruritus—Fluorouracil—pancreatic cancer	8.94e-05	0.000387	CcSEcCtD
Rabeprazole—Thrombocytopenia—Docetaxel—pancreatic cancer	8.93e-05	0.000386	CcSEcCtD
Rabeprazole—Tachycardia—Docetaxel—pancreatic cancer	8.9e-05	0.000385	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.85e-05	0.000383	CcSEcCtD
Rabeprazole—Bradycardia—Epirubicin—pancreatic cancer	8.82e-05	0.000381	CcSEcCtD
Rabeprazole—Diarrhoea—Gemcitabine—pancreatic cancer	8.8e-05	0.00038	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Doxorubicin—pancreatic cancer	8.75e-05	0.000378	CcSEcCtD
Rabeprazole—Dizziness—Irinotecan—pancreatic cancer	8.73e-05	0.000377	CcSEcCtD
Rabeprazole—Stomatitis—Doxorubicin—pancreatic cancer	8.7e-05	0.000376	CcSEcCtD
Rabeprazole—Jaundice—Doxorubicin—pancreatic cancer	8.7e-05	0.000376	CcSEcCtD
Rabeprazole—Anorexia—Docetaxel—pancreatic cancer	8.7e-05	0.000376	CcSEcCtD
Rabeprazole—Rhinitis—Epirubicin—pancreatic cancer	8.68e-05	0.000375	CcSEcCtD
Rabeprazole—Conjunctivitis—Doxorubicin—pancreatic cancer	8.68e-05	0.000375	CcSEcCtD
Rabeprazole—Urinary tract infection—Doxorubicin—pancreatic cancer	8.68e-05	0.000375	CcSEcCtD
Rabeprazole—Hepatitis—Epirubicin—pancreatic cancer	8.66e-05	0.000374	CcSEcCtD
Rabeprazole—Diarrhoea—Fluorouracil—pancreatic cancer	8.65e-05	0.000374	CcSEcCtD
Rabeprazole—Pharyngitis—Epirubicin—pancreatic cancer	8.6e-05	0.000372	CcSEcCtD
Rabeprazole—Sweating—Doxorubicin—pancreatic cancer	8.56e-05	0.00037	CcSEcCtD
Rabeprazole—Urinary tract disorder—Epirubicin—pancreatic cancer	8.55e-05	0.00037	CcSEcCtD
Rabeprazole—Oedema peripheral—Epirubicin—pancreatic cancer	8.53e-05	0.000369	CcSEcCtD
Rabeprazole—Hypotension—Docetaxel—pancreatic cancer	8.52e-05	0.000369	CcSEcCtD
Rabeprazole—Haematuria—Doxorubicin—pancreatic cancer	8.51e-05	0.000368	CcSEcCtD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	8.5e-05	0.00133	CbGpPWpGaD
Rabeprazole—Urethral disorder—Epirubicin—pancreatic cancer	8.49e-05	0.000367	CcSEcCtD
Rabeprazole—Epistaxis—Doxorubicin—pancreatic cancer	8.42e-05	0.000364	CcSEcCtD
Rabeprazole—Vomiting—Irinotecan—pancreatic cancer	8.39e-05	0.000363	CcSEcCtD
Rabeprazole—Sinusitis—Doxorubicin—pancreatic cancer	8.38e-05	0.000362	CcSEcCtD
Rabeprazole—Dizziness—Fluorouracil—pancreatic cancer	8.36e-05	0.000361	CcSEcCtD
Rabeprazole—Visual impairment—Epirubicin—pancreatic cancer	8.35e-05	0.000361	CcSEcCtD
Rabeprazole—Agranulocytosis—Doxorubicin—pancreatic cancer	8.33e-05	0.00036	CcSEcCtD
Rabeprazole—Rash—Irinotecan—pancreatic cancer	8.32e-05	0.00036	CcSEcCtD
Rabeprazole—Dermatitis—Irinotecan—pancreatic cancer	8.31e-05	0.000359	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	8.31e-05	0.000359	CcSEcCtD
Rabeprazole—Headache—Irinotecan—pancreatic cancer	8.27e-05	0.000357	CcSEcCtD
Rabeprazole—Insomnia—Docetaxel—pancreatic cancer	8.25e-05	0.000357	CcSEcCtD
Rabeprazole—Paraesthesia—Docetaxel—pancreatic cancer	8.19e-05	0.000354	CcSEcCtD
Rabeprazole—Erythema multiforme—Epirubicin—pancreatic cancer	8.19e-05	0.000354	CcSEcCtD
Rabeprazole—Vomiting—Gemcitabine—pancreatic cancer	8.17e-05	0.000353	CcSEcCtD
Rabeprazole—Bradycardia—Doxorubicin—pancreatic cancer	8.16e-05	0.000353	CcSEcCtD
Rabeprazole—Dyspnoea—Docetaxel—pancreatic cancer	8.13e-05	0.000352	CcSEcCtD
Rabeprazole—Somnolence—Docetaxel—pancreatic cancer	8.11e-05	0.000351	CcSEcCtD
Rabeprazole—Rash—Gemcitabine—pancreatic cancer	8.11e-05	0.00035	CcSEcCtD
Rabeprazole—Dermatitis—Gemcitabine—pancreatic cancer	8.1e-05	0.00035	CcSEcCtD
Rabeprazole—Eye disorder—Epirubicin—pancreatic cancer	8.09e-05	0.00035	CcSEcCtD
Rabeprazole—Tinnitus—Epirubicin—pancreatic cancer	8.08e-05	0.000349	CcSEcCtD
Rabeprazole—Headache—Gemcitabine—pancreatic cancer	8.05e-05	0.000348	CcSEcCtD
Rabeprazole—Vomiting—Fluorouracil—pancreatic cancer	8.04e-05	0.000347	CcSEcCtD
Rabeprazole—Rhinitis—Doxorubicin—pancreatic cancer	8.03e-05	0.000347	CcSEcCtD
Rabeprazole—Dyspepsia—Docetaxel—pancreatic cancer	8.03e-05	0.000347	CcSEcCtD
Rabeprazole—Hepatitis—Doxorubicin—pancreatic cancer	8.01e-05	0.000347	CcSEcCtD
Rabeprazole—Rash—Fluorouracil—pancreatic cancer	7.97e-05	0.000345	CcSEcCtD
Rabeprazole—Dermatitis—Fluorouracil—pancreatic cancer	7.96e-05	0.000344	CcSEcCtD
Rabeprazole—Pharyngitis—Doxorubicin—pancreatic cancer	7.95e-05	0.000344	CcSEcCtD
Rabeprazole—Decreased appetite—Docetaxel—pancreatic cancer	7.93e-05	0.000343	CcSEcCtD
Rabeprazole—Headache—Fluorouracil—pancreatic cancer	7.92e-05	0.000342	CcSEcCtD
Rabeprazole—Urinary tract disorder—Doxorubicin—pancreatic cancer	7.91e-05	0.000342	CcSEcCtD
Rabeprazole—Oedema peripheral—Doxorubicin—pancreatic cancer	7.89e-05	0.000341	CcSEcCtD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	7.89e-05	0.00123	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	7.89e-05	0.00123	CbGpPWpGaD
Rabeprazole—Angiopathy—Epirubicin—pancreatic cancer	7.86e-05	0.00034	CcSEcCtD
Rabeprazole—Urethral disorder—Doxorubicin—pancreatic cancer	7.86e-05	0.00034	CcSEcCtD
Rabeprazole—Nausea—Irinotecan—pancreatic cancer	7.84e-05	0.000339	CcSEcCtD
Rabeprazole—Constipation—Docetaxel—pancreatic cancer	7.8e-05	0.000337	CcSEcCtD
Rabeprazole—Pain—Docetaxel—pancreatic cancer	7.8e-05	0.000337	CcSEcCtD
Rabeprazole—Chills—Epirubicin—pancreatic cancer	7.77e-05	0.000336	CcSEcCtD
Rabeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	7.77e-05	0.00121	CbGpPWpGaD
Rabeprazole—Arrhythmia—Epirubicin—pancreatic cancer	7.74e-05	0.000335	CcSEcCtD
Rabeprazole—Visual impairment—Doxorubicin—pancreatic cancer	7.72e-05	0.000334	CcSEcCtD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	7.68e-05	0.0012	CbGpPWpGaD
Rabeprazole—Alopecia—Epirubicin—pancreatic cancer	7.65e-05	0.000331	CcSEcCtD
Rabeprazole—Nausea—Gemcitabine—pancreatic cancer	7.64e-05	0.00033	CcSEcCtD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	7.59e-05	0.00119	CbGpPWpGaD
Rabeprazole—Erythema multiforme—Doxorubicin—pancreatic cancer	7.58e-05	0.000328	CcSEcCtD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	7.57e-05	0.00118	CbGpPWpGaD
Rabeprazole—Erythema—Epirubicin—pancreatic cancer	7.54e-05	0.000326	CcSEcCtD
Rabeprazole—Malnutrition—Epirubicin—pancreatic cancer	7.54e-05	0.000326	CcSEcCtD
Rabeprazole—Feeling abnormal—Docetaxel—pancreatic cancer	7.52e-05	0.000325	CcSEcCtD
Rabeprazole—Nausea—Fluorouracil—pancreatic cancer	7.51e-05	0.000325	CcSEcCtD
Rabeprazole—Eye disorder—Doxorubicin—pancreatic cancer	7.49e-05	0.000324	CcSEcCtD
Rabeprazole—Tinnitus—Doxorubicin—pancreatic cancer	7.47e-05	0.000323	CcSEcCtD
Rabeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatic cancer	7.47e-05	0.00117	CbGpPWpGaD
Rabeprazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	7.46e-05	0.000323	CcSEcCtD
Rabeprazole—Flatulence—Epirubicin—pancreatic cancer	7.43e-05	0.000321	CcSEcCtD
Rabeprazole—Tension—Epirubicin—pancreatic cancer	7.4e-05	0.00032	CcSEcCtD
Rabeprazole—Dysgeusia—Epirubicin—pancreatic cancer	7.38e-05	0.000319	CcSEcCtD
Rabeprazole—Nervousness—Epirubicin—pancreatic cancer	7.32e-05	0.000317	CcSEcCtD
Rabeprazole—Back pain—Epirubicin—pancreatic cancer	7.29e-05	0.000315	CcSEcCtD
Rabeprazole—Angiopathy—Doxorubicin—pancreatic cancer	7.27e-05	0.000314	CcSEcCtD
Rabeprazole—Muscle spasms—Epirubicin—pancreatic cancer	7.25e-05	0.000313	CcSEcCtD
Rabeprazole—Body temperature increased—Docetaxel—pancreatic cancer	7.21e-05	0.000312	CcSEcCtD
Rabeprazole—Abdominal pain—Docetaxel—pancreatic cancer	7.21e-05	0.000312	CcSEcCtD
Rabeprazole—Chills—Doxorubicin—pancreatic cancer	7.19e-05	0.000311	CcSEcCtD
Rabeprazole—Arrhythmia—Doxorubicin—pancreatic cancer	7.16e-05	0.00031	CcSEcCtD
Rabeprazole—Vision blurred—Epirubicin—pancreatic cancer	7.11e-05	0.000307	CcSEcCtD
Rabeprazole—Alopecia—Doxorubicin—pancreatic cancer	7.08e-05	0.000306	CcSEcCtD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	7.07e-05	0.0011	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	7.05e-05	0.0011	CbGpPWpGaD
Rabeprazole—Ill-defined disorder—Epirubicin—pancreatic cancer	7e-05	0.000302	CcSEcCtD
Rabeprazole—Malnutrition—Doxorubicin—pancreatic cancer	6.98e-05	0.000302	CcSEcCtD
Rabeprazole—Erythema—Doxorubicin—pancreatic cancer	6.98e-05	0.000302	CcSEcCtD
Rabeprazole—Anaemia—Epirubicin—pancreatic cancer	6.97e-05	0.000301	CcSEcCtD
Rabeprazole—Agitation—Epirubicin—pancreatic cancer	6.93e-05	0.0003	CcSEcCtD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	6.91e-05	0.00108	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	6.91e-05	0.00108	CbGpPWpGaD
Rabeprazole—Flatulence—Doxorubicin—pancreatic cancer	6.87e-05	0.000297	CcSEcCtD
Rabeprazole—Tension—Doxorubicin—pancreatic cancer	6.85e-05	0.000296	CcSEcCtD
Rabeprazole—Dysgeusia—Doxorubicin—pancreatic cancer	6.83e-05	0.000295	CcSEcCtD
Rabeprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	6.81e-05	0.00106	CbGpPWpGaD
Rabeprazole—Malaise—Epirubicin—pancreatic cancer	6.8e-05	0.000294	CcSEcCtD
Rabeprazole—Nervousness—Doxorubicin—pancreatic cancer	6.78e-05	0.000293	CcSEcCtD
Rabeprazole—Vertigo—Epirubicin—pancreatic cancer	6.77e-05	0.000293	CcSEcCtD
Rabeprazole—Syncope—Epirubicin—pancreatic cancer	6.76e-05	0.000292	CcSEcCtD
Rabeprazole—Leukopenia—Epirubicin—pancreatic cancer	6.75e-05	0.000292	CcSEcCtD
Rabeprazole—Back pain—Doxorubicin—pancreatic cancer	6.75e-05	0.000292	CcSEcCtD
Rabeprazole—Hypersensitivity—Docetaxel—pancreatic cancer	6.72e-05	0.000291	CcSEcCtD
Rabeprazole—Muscle spasms—Doxorubicin—pancreatic cancer	6.71e-05	0.00029	CcSEcCtD
Rabeprazole—Palpitations—Epirubicin—pancreatic cancer	6.66e-05	0.000288	CcSEcCtD
Rabeprazole—Loss of consciousness—Epirubicin—pancreatic cancer	6.63e-05	0.000287	CcSEcCtD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	6.59e-05	0.00103	CbGpPWpGaD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	6.59e-05	0.00103	CbGpPWpGaD
Rabeprazole—Cough—Epirubicin—pancreatic cancer	6.58e-05	0.000284	CcSEcCtD
Rabeprazole—Vision blurred—Doxorubicin—pancreatic cancer	6.57e-05	0.000284	CcSEcCtD
Rabeprazole—Asthenia—Docetaxel—pancreatic cancer	6.55e-05	0.000283	CcSEcCtD
Rabeprazole—Convulsion—Epirubicin—pancreatic cancer	6.53e-05	0.000282	CcSEcCtD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	6.53e-05	0.00102	CbGpPWpGaD
Rabeprazole—Hypertension—Epirubicin—pancreatic cancer	6.51e-05	0.000281	CcSEcCtD
Rabeprazole—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.47e-05	0.00028	CcSEcCtD
Rabeprazole—Pruritus—Docetaxel—pancreatic cancer	6.45e-05	0.000279	CcSEcCtD
Rabeprazole—Anaemia—Doxorubicin—pancreatic cancer	6.45e-05	0.000279	CcSEcCtD
Rabeprazole—Chest pain—Epirubicin—pancreatic cancer	6.42e-05	0.000278	CcSEcCtD
Rabeprazole—Arthralgia—Epirubicin—pancreatic cancer	6.42e-05	0.000278	CcSEcCtD
Rabeprazole—Myalgia—Epirubicin—pancreatic cancer	6.42e-05	0.000278	CcSEcCtD
Rabeprazole—Agitation—Doxorubicin—pancreatic cancer	6.41e-05	0.000277	CcSEcCtD
Rabeprazole—Anxiety—Epirubicin—pancreatic cancer	6.4e-05	0.000277	CcSEcCtD
Rabeprazole—Discomfort—Epirubicin—pancreatic cancer	6.34e-05	0.000274	CcSEcCtD
Rabeprazole—Malaise—Doxorubicin—pancreatic cancer	6.29e-05	0.000272	CcSEcCtD
Rabeprazole—Dry mouth—Epirubicin—pancreatic cancer	6.28e-05	0.000271	CcSEcCtD
Rabeprazole—Vertigo—Doxorubicin—pancreatic cancer	6.27e-05	0.000271	CcSEcCtD
Rabeprazole—Syncope—Doxorubicin—pancreatic cancer	6.26e-05	0.000271	CcSEcCtD
Rabeprazole—Leukopenia—Doxorubicin—pancreatic cancer	6.24e-05	0.00027	CcSEcCtD
Rabeprazole—Diarrhoea—Docetaxel—pancreatic cancer	6.24e-05	0.00027	CcSEcCtD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	6.22e-05	0.000971	CbGpPWpGaD
Rabeprazole—Confusional state—Epirubicin—pancreatic cancer	6.2e-05	0.000268	CcSEcCtD
Rabeprazole—CYP1A1—PPARA activates gene expression—PPARG—pancreatic cancer	6.17e-05	0.000964	CbGpPWpGaD
Rabeprazole—Palpitations—Doxorubicin—pancreatic cancer	6.16e-05	0.000267	CcSEcCtD
Rabeprazole—Oedema—Epirubicin—pancreatic cancer	6.15e-05	0.000266	CcSEcCtD
Rabeprazole—Anaphylactic shock—Epirubicin—pancreatic cancer	6.15e-05	0.000266	CcSEcCtD
Rabeprazole—Loss of consciousness—Doxorubicin—pancreatic cancer	6.13e-05	0.000265	CcSEcCtD
Rabeprazole—Cough—Doxorubicin—pancreatic cancer	6.09e-05	0.000263	CcSEcCtD
Rabeprazole—Shock—Epirubicin—pancreatic cancer	6.05e-05	0.000262	CcSEcCtD
Rabeprazole—Convulsion—Doxorubicin—pancreatic cancer	6.04e-05	0.000261	CcSEcCtD
Rabeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—pancreatic cancer	6.04e-05	0.000944	CbGpPWpGaD
Rabeprazole—Dizziness—Docetaxel—pancreatic cancer	6.03e-05	0.000261	CcSEcCtD
Rabeprazole—Thrombocytopenia—Epirubicin—pancreatic cancer	6.02e-05	0.000261	CcSEcCtD
Rabeprazole—Hypertension—Doxorubicin—pancreatic cancer	6.02e-05	0.00026	CcSEcCtD
Rabeprazole—Tachycardia—Epirubicin—pancreatic cancer	6.01e-05	0.00026	CcSEcCtD
Rabeprazole—Hyperhidrosis—Epirubicin—pancreatic cancer	5.95e-05	0.000257	CcSEcCtD
Rabeprazole—Arthralgia—Doxorubicin—pancreatic cancer	5.94e-05	0.000257	CcSEcCtD
Rabeprazole—Chest pain—Doxorubicin—pancreatic cancer	5.94e-05	0.000257	CcSEcCtD
Rabeprazole—Myalgia—Doxorubicin—pancreatic cancer	5.94e-05	0.000257	CcSEcCtD
Rabeprazole—Anxiety—Doxorubicin—pancreatic cancer	5.92e-05	0.000256	CcSEcCtD
Rabeprazole—Discomfort—Doxorubicin—pancreatic cancer	5.87e-05	0.000254	CcSEcCtD
Rabeprazole—Anorexia—Epirubicin—pancreatic cancer	5.87e-05	0.000254	CcSEcCtD
Rabeprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	5.82e-05	0.000909	CbGpPWpGaD
Rabeprazole—Dry mouth—Doxorubicin—pancreatic cancer	5.81e-05	0.000251	CcSEcCtD
Rabeprazole—Vomiting—Docetaxel—pancreatic cancer	5.8e-05	0.000251	CcSEcCtD
Rabeprazole—Rash—Docetaxel—pancreatic cancer	5.75e-05	0.000249	CcSEcCtD
Rabeprazole—Hypotension—Epirubicin—pancreatic cancer	5.75e-05	0.000249	CcSEcCtD
Rabeprazole—Dermatitis—Docetaxel—pancreatic cancer	5.75e-05	0.000248	CcSEcCtD
Rabeprazole—Confusional state—Doxorubicin—pancreatic cancer	5.74e-05	0.000248	CcSEcCtD
Rabeprazole—Headache—Docetaxel—pancreatic cancer	5.72e-05	0.000247	CcSEcCtD
Rabeprazole—Anaphylactic shock—Doxorubicin—pancreatic cancer	5.69e-05	0.000246	CcSEcCtD
Rabeprazole—Oedema—Doxorubicin—pancreatic cancer	5.69e-05	0.000246	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.61e-05	0.000242	CcSEcCtD
Rabeprazole—Shock—Doxorubicin—pancreatic cancer	5.6e-05	0.000242	CcSEcCtD
Rabeprazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.57e-05	0.000241	CcSEcCtD
Rabeprazole—Insomnia—Epirubicin—pancreatic cancer	5.57e-05	0.000241	CcSEcCtD
Rabeprazole—Tachycardia—Doxorubicin—pancreatic cancer	5.56e-05	0.00024	CcSEcCtD
Rabeprazole—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	5.55e-05	0.000867	CbGpPWpGaD
Rabeprazole—Paraesthesia—Epirubicin—pancreatic cancer	5.53e-05	0.000239	CcSEcCtD
Rabeprazole—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.5e-05	0.000238	CcSEcCtD
Rabeprazole—Dyspnoea—Epirubicin—pancreatic cancer	5.49e-05	0.000237	CcSEcCtD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.47e-05	0.000855	CbGpPWpGaD
Rabeprazole—Somnolence—Epirubicin—pancreatic cancer	5.47e-05	0.000237	CcSEcCtD
Rabeprazole—Anorexia—Doxorubicin—pancreatic cancer	5.43e-05	0.000235	CcSEcCtD
Rabeprazole—ABCG2—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	5.43e-05	0.000847	CbGpPWpGaD
Rabeprazole—Nausea—Docetaxel—pancreatic cancer	5.42e-05	0.000234	CcSEcCtD
Rabeprazole—Dyspepsia—Epirubicin—pancreatic cancer	5.42e-05	0.000234	CcSEcCtD
Rabeprazole—Decreased appetite—Epirubicin—pancreatic cancer	5.35e-05	0.000231	CcSEcCtD
Rabeprazole—Hypotension—Doxorubicin—pancreatic cancer	5.32e-05	0.00023	CcSEcCtD
Rabeprazole—Pain—Epirubicin—pancreatic cancer	5.26e-05	0.000228	CcSEcCtD
Rabeprazole—Constipation—Epirubicin—pancreatic cancer	5.26e-05	0.000228	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	5.19e-05	0.000224	CcSEcCtD
Rabeprazole—Insomnia—Doxorubicin—pancreatic cancer	5.15e-05	0.000223	CcSEcCtD
Rabeprazole—Paraesthesia—Doxorubicin—pancreatic cancer	5.11e-05	0.000221	CcSEcCtD
Rabeprazole—Dyspnoea—Doxorubicin—pancreatic cancer	5.08e-05	0.000219	CcSEcCtD
Rabeprazole—Feeling abnormal—Epirubicin—pancreatic cancer	5.07e-05	0.000219	CcSEcCtD
Rabeprazole—Somnolence—Doxorubicin—pancreatic cancer	5.06e-05	0.000219	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.03e-05	0.000218	CcSEcCtD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	5.03e-05	0.000786	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	5.03e-05	0.000786	CbGpPWpGaD
Rabeprazole—Dyspepsia—Doxorubicin—pancreatic cancer	5.01e-05	0.000217	CcSEcCtD
Rabeprazole—Decreased appetite—Doxorubicin—pancreatic cancer	4.95e-05	0.000214	CcSEcCtD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	4.9e-05	0.000765	CbGpPWpGaD
Rabeprazole—Urticaria—Epirubicin—pancreatic cancer	4.89e-05	0.000211	CcSEcCtD
Rabeprazole—Pain—Doxorubicin—pancreatic cancer	4.87e-05	0.000211	CcSEcCtD
Rabeprazole—Constipation—Doxorubicin—pancreatic cancer	4.87e-05	0.000211	CcSEcCtD
Rabeprazole—Abdominal pain—Epirubicin—pancreatic cancer	4.86e-05	0.00021	CcSEcCtD
Rabeprazole—Body temperature increased—Epirubicin—pancreatic cancer	4.86e-05	0.00021	CcSEcCtD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	4.84e-05	0.000756	CbGpPWpGaD
Rabeprazole—Feeling abnormal—Doxorubicin—pancreatic cancer	4.69e-05	0.000203	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.66e-05	0.000201	CcSEcCtD
Rabeprazole—Hypersensitivity—Epirubicin—pancreatic cancer	4.53e-05	0.000196	CcSEcCtD
Rabeprazole—Urticaria—Doxorubicin—pancreatic cancer	4.52e-05	0.000196	CcSEcCtD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	4.51e-05	0.000704	CbGpPWpGaD
Rabeprazole—Body temperature increased—Doxorubicin—pancreatic cancer	4.5e-05	0.000195	CcSEcCtD
Rabeprazole—Abdominal pain—Doxorubicin—pancreatic cancer	4.5e-05	0.000195	CcSEcCtD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	4.5e-05	0.000702	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PRSS1—pancreatic cancer	4.5e-05	0.000702	CbGpPWpGaD
Rabeprazole—Asthenia—Epirubicin—pancreatic cancer	4.41e-05	0.000191	CcSEcCtD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	4.41e-05	0.000689	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	4.41e-05	0.000689	CbGpPWpGaD
Rabeprazole—Pruritus—Epirubicin—pancreatic cancer	4.35e-05	0.000188	CcSEcCtD
Rabeprazole—Diarrhoea—Epirubicin—pancreatic cancer	4.21e-05	0.000182	CcSEcCtD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	4.2e-05	0.000656	CbGpPWpGaD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	4.2e-05	0.000656	CbGpPWpGaD
Rabeprazole—Hypersensitivity—Doxorubicin—pancreatic cancer	4.19e-05	0.000181	CcSEcCtD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	4.17e-05	0.00065	CbGpPWpGaD
Rabeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—pancreatic cancer	4.16e-05	0.00065	CbGpPWpGaD
Rabeprazole—Asthenia—Doxorubicin—pancreatic cancer	4.08e-05	0.000177	CcSEcCtD
Rabeprazole—Dizziness—Epirubicin—pancreatic cancer	4.07e-05	0.000176	CcSEcCtD
Rabeprazole—Pruritus—Doxorubicin—pancreatic cancer	4.03e-05	0.000174	CcSEcCtD
Rabeprazole—Vomiting—Epirubicin—pancreatic cancer	3.91e-05	0.000169	CcSEcCtD
Rabeprazole—ABCG2—Metabolism—ARG2—pancreatic cancer	3.9e-05	0.000609	CbGpPWpGaD
Rabeprazole—Diarrhoea—Doxorubicin—pancreatic cancer	3.9e-05	0.000168	CcSEcCtD
Rabeprazole—Rash—Epirubicin—pancreatic cancer	3.88e-05	0.000168	CcSEcCtD
Rabeprazole—Dermatitis—Epirubicin—pancreatic cancer	3.88e-05	0.000168	CcSEcCtD
Rabeprazole—Headache—Epirubicin—pancreatic cancer	3.85e-05	0.000167	CcSEcCtD
Rabeprazole—Dizziness—Doxorubicin—pancreatic cancer	3.77e-05	0.000163	CcSEcCtD
Rabeprazole—Nausea—Epirubicin—pancreatic cancer	3.65e-05	0.000158	CcSEcCtD
Rabeprazole—Vomiting—Doxorubicin—pancreatic cancer	3.62e-05	0.000157	CcSEcCtD
Rabeprazole—Rash—Doxorubicin—pancreatic cancer	3.59e-05	0.000155	CcSEcCtD
Rabeprazole—Dermatitis—Doxorubicin—pancreatic cancer	3.59e-05	0.000155	CcSEcCtD
Rabeprazole—Headache—Doxorubicin—pancreatic cancer	3.57e-05	0.000154	CcSEcCtD
Rabeprazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	3.54e-05	0.000553	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—TYMP—pancreatic cancer	3.41e-05	0.000532	CbGpPWpGaD
Rabeprazole—Nausea—Doxorubicin—pancreatic cancer	3.38e-05	0.000146	CcSEcCtD
Rabeprazole—CYP1A1—Metabolism—PRSS1—pancreatic cancer	3.04e-05	0.000475	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GLP1R—pancreatic cancer	2.75e-05	0.000429	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—DPYD—pancreatic cancer	2.7e-05	0.000422	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ARG2—pancreatic cancer	2.64e-05	0.000412	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—SLC2A2—pancreatic cancer	2.56e-05	0.0004	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PRSS1—pancreatic cancer	2.49e-05	0.000389	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—TYMP—pancreatic cancer	2.31e-05	0.00036	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PRSS1—pancreatic cancer	2.29e-05	0.000358	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PRSS1—pancreatic cancer	2.27e-05	0.000355	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ARG2—pancreatic cancer	2.16e-05	0.000337	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.99e-05	0.00031	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CD44—pancreatic cancer	1.99e-05	0.00031	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.97e-05	0.000308	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.94e-05	0.000303	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GCG—pancreatic cancer	1.9e-05	0.000297	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.9e-05	0.000297	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.89e-05	0.000295	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GLP1R—pancreatic cancer	1.86e-05	0.00029	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—DPYD—pancreatic cancer	1.83e-05	0.000286	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—STK11—pancreatic cancer	1.79e-05	0.00028	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.74e-05	0.000271	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	1.74e-05	0.000271	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.72e-05	0.000269	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.72e-05	0.000268	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.68e-05	0.000263	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.66e-05	0.000259	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.56e-05	0.000243	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—TYMS—pancreatic cancer	1.54e-05	0.00024	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GLP1R—pancreatic cancer	1.52e-05	0.000238	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.51e-05	0.000236	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.5e-05	0.000234	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—DPYD—pancreatic cancer	1.5e-05	0.000234	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.47e-05	0.00023	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	1.42e-05	0.000222	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.42e-05	0.000222	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.41e-05	0.00022	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.4e-05	0.000219	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.39e-05	0.000217	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.38e-05	0.000215	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.36e-05	0.000213	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.36e-05	0.000212	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CD44—pancreatic cancer	1.34e-05	0.00021	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.32e-05	0.000206	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.31e-05	0.000204	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.3e-05	0.000204	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.3e-05	0.000203	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	1.3e-05	0.000202	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GCG—pancreatic cancer	1.29e-05	0.000201	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.28e-05	0.0002	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—APOE—pancreatic cancer	1.25e-05	0.000196	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.24e-05	0.000193	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.24e-05	0.000193	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.21e-05	0.00019	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—STK11—pancreatic cancer	1.21e-05	0.000189	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GLP1R—pancreatic cancer	1.19e-05	0.000185	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—DPYD—pancreatic cancer	1.17e-05	0.000182	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.14e-05	0.000178	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.14e-05	0.000177	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CG—pancreatic cancer	1.13e-05	0.000176	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.13e-05	0.000176	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	1.11e-05	0.000173	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CD44—pancreatic cancer	1.1e-05	0.000172	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.1e-05	0.000171	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PPARG—pancreatic cancer	1.09e-05	0.00017	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.08e-05	0.000168	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.07e-05	0.000167	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.06e-05	0.000165	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GCG—pancreatic cancer	1.05e-05	0.000165	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—TYMS—pancreatic cancer	1.04e-05	0.000163	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CD44—pancreatic cancer	1.01e-05	0.000158	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CD44—pancreatic cancer	1e-05	0.000157	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CD—pancreatic cancer	9.93e-06	0.000155	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—STK11—pancreatic cancer	9.91e-06	0.000155	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	9.82e-06	0.000153	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	9.73e-06	0.000152	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GCG—pancreatic cancer	9.7e-06	0.000151	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.63e-06	0.00015	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GCG—pancreatic cancer	9.62e-06	0.00015	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	9.31e-06	0.000145	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GLP1R—pancreatic cancer	9.15e-06	0.000143	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—STK11—pancreatic cancer	9.12e-06	0.000142	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—STK11—pancreatic cancer	9.04e-06	0.000141	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—DPYD—pancreatic cancer	9e-06	0.000141	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CB—pancreatic cancer	8.66e-06	0.000135	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS2—pancreatic cancer	8.58e-06	0.000134	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CD44—pancreatic cancer	8.57e-06	0.000134	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	8.54e-06	0.000133	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—TYMS—pancreatic cancer	8.53e-06	0.000133	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.49e-06	0.000133	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—APOE—pancreatic cancer	8.48e-06	0.000132	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.39e-06	0.000131	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.32e-06	0.00013	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GCG—pancreatic cancer	8.22e-06	0.000128	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	8.02e-06	0.000125	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—TYMS—pancreatic cancer	7.84e-06	0.000123	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—TYMS—pancreatic cancer	7.78e-06	0.000121	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—STK11—pancreatic cancer	7.73e-06	0.000121	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	7.65e-06	0.000119	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTEN—pancreatic cancer	7.48e-06	0.000117	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PPARG—pancreatic cancer	7.38e-06	0.000115	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.25e-06	0.000113	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APOE—pancreatic cancer	6.94e-06	0.000108	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	6.72e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—TYMS—pancreatic cancer	6.65e-06	0.000104	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CD44—pancreatic cancer	6.61e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.57e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APOE—pancreatic cancer	6.38e-06	9.96e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GCG—pancreatic cancer	6.34e-06	9.9e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APOE—pancreatic cancer	6.32e-06	9.88e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	6.26e-06	9.78e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPARG—pancreatic cancer	6.04e-06	9.44e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.99e-06	9.35e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—STK11—pancreatic cancer	5.96e-06	9.31e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	5.86e-06	9.15e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS2—pancreatic cancer	5.81e-06	9.07e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	5.76e-06	8.99e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	5.71e-06	8.91e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPARG—pancreatic cancer	5.56e-06	8.68e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPARG—pancreatic cancer	5.51e-06	8.6e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	5.5e-06	8.59e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APOE—pancreatic cancer	5.4e-06	8.44e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CA—pancreatic cancer	5.28e-06	8.24e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.13e-06	8.01e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.12e-06	7.99e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTEN—pancreatic cancer	5.07e-06	7.91e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	5.06e-06	7.91e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	5.02e-06	7.84e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	4.88e-06	7.62e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	4.8e-06	7.49e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS2—pancreatic cancer	4.75e-06	7.42e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPARG—pancreatic cancer	4.71e-06	7.35e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	4.41e-06	6.89e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	4.37e-06	6.83e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS2—pancreatic cancer	4.37e-06	6.83e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS2—pancreatic cancer	4.33e-06	6.77e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—AKT1—pancreatic cancer	4.31e-06	6.73e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	4.29e-06	6.7e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APOE—pancreatic cancer	4.17e-06	6.51e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTEN—pancreatic cancer	4.14e-06	6.47e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTEN—pancreatic cancer	3.81e-06	5.95e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTEN—pancreatic cancer	3.78e-06	5.9e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.76e-06	5.88e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	3.74e-06	5.84e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS2—pancreatic cancer	3.7e-06	5.78e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.63e-06	5.67e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	3.57e-06	5.58e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.31e-06	5.17e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTEN—pancreatic cancer	3.23e-06	5.04e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2.92e-06	4.57e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—AKT1—pancreatic cancer	2.92e-06	4.56e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.88e-06	4.5e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.86e-06	4.46e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.69e-06	4.2e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	2.67e-06	4.16e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.49e-06	3.89e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—AKT1—pancreatic cancer	2.39e-06	3.73e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	2.28e-06	3.56e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—AKT1—pancreatic cancer	2.2e-06	3.43e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—AKT1—pancreatic cancer	2.18e-06	3.4e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.86e-06	2.91e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.76e-06	2.75e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.44e-06	2.24e-05	CbGpPWpGaD
